Back to news
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
ICREA Research Professor Thomas Sturm (UAB) will participate in the ecas-Europe 2026 State of the Union Citizens’ Rights Conference, talking about the “Fifth Freedom”, the freedom of knowledge
Prof. Thomas Sturm will be contributing to the second panel on the Fifth Freedom within the European Union. The conference…
Catalan National Research Awards 2025
ICREA researchers Luis Serrano and Katherine Villa have been awarded at the 36th edition of the 'Premis Nacionals de Recerca'…
